Search

Your search keyword '"Vehreschild, Janne"' showing total 10 results
Start Over Author "Vehreschild, Janne" Publisher springer berlin heidelberg
10 results on '"Vehreschild, Janne"'

2. Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)

Author

Steinbeis, Fridolin, Thibeault, Charlotte, Steinbrecher, Sarah, Ahlgrimm, Yvonne, Haack, Ira an, August, Dietrich, Balzuweit, Beate, Bellinghausen, Carla, Berger, Sarah, Chaplinskaya-Sobol, Irina, Cornely, Oliver, Doeblin, Patrick, Endres, Matthias, Fink, Claudia, Finke, Carsten, Frank, Sandra, Hanß, Sabine, Hartung, Tim, Hellmuth, Johannes Christian, Herold, Susanne, Heuschmann, Peter, Heyckendorf, Jan, Heyder, Ralf, Hippenstiel, Stefan, Hoffmann, Wolfgang, Kelle, Sebastian Ulrich, Knape, Philipp, Koehler, Philipp, Kretzler, Lucie, Leistner, David Manuel, Lienau, Jasmin, Lorbeer, Roberto, Lorenz-Depiereux, Bettina, Lüttke, Constanze Dorothea, Mai, Knut, Merle, Uta, Meyer-Arndt, Lil Antonia, Miljukov, Olga, Muenchhoff, Maximilian, Müller-Plathe, Moritz, Neuhann, Julia, Neuhauser, Hannelore, Nieters, Alexandra, Otte, Christian, Pape, Daniel, Pinto, Rafaela Maria, Pley, Christina, Pudszuhn, Annett, Reuken, Philipp, Rieg, Siegberg, Ritter, Petra, Rohde, Gernot, Rönnefarth, Maria, Ruzicka, Michael, Schaller, Jens, Schmidt, Anne, Schmidt, Sein, Schwachmeyer, Verena, Schwanitz, Georg, Seeger, Werner, Stahl, Dana, Stobäus, Nicole, Stubbe, Hans Christian, Suttorp, Norbert, Temmesfeld, Bettina, Thun, Sylvia, Triller, Paul, Trinkmann, Frederik, Vadasz, Istvan, Valentin, Heike, Vehreschild, Maria, von Kalle, Christof, von Lilienfeld-Toal, Marie, Weber, Joachim, Welte, Tobias, Wildberg, Christian, Wizimirski, Robert, Zvork, Saskia, Sander, Leif Erik, Vehreschild, Janne, Zoller, Thomas, Kurth, Florian, and Witzenrath, Martin

Published
2024
Full Text
View/download PDF

5. All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

Author

Schons, Maximilian J., Caliebe, Amke, Spinner, Christoph D., Classen, Annika Y., Pilgram, Lisa, Ruethrich, Maria M., Rupp, Jan, Nunes de Miranda, Susana M., Römmele, Christoph, Vehreschild, Janne, Jensen, Bjoern-Erik, Vehreschild, Maria, Degenhardt, Christian, Borgmann, Stefan, Hower, Martin, Hanses, Frank, Haselberger, Martina, and Friedrichs, Anette K.

Published
2022
Full Text
View/download PDF

6. Correction to: All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

Author

Schons, Maximilian J., Caliebe, Amke, Spinner, Christoph D., Classen, Annika Y., Pilgram, Lisa, Ruethrich, Maria M., Rupp, Jan, Nunes de Miranda, Susana M., Römmele, Christoph, Vehreschild, Janne, Jensen, Bjoern-Erik, Vehreschild, Maria, Degenhardt, Christian, Borgmann, Stefan, Hower, Martin, Hanses, Frank, Haselberger, Martina, and Friedrichs, Anette K.

Published
2022
Full Text
View/download PDF

7. Transplantationsmedizin in der Intensivmedizin

Author

Michels, Guido, Ruhparwar, Arjang, Welte, Tobias, Gottlieb, Jens, Teschner, Sven, Burst, Volker, Mertens, Jessica, Stippel, Dirk, Herter-Sprie, Grit, von Bergwelt-Baildon, Michael, Theurich, Sebastian, Vehreschild, Janne, Scheid, Christoph, Chemnitz, Jens, Kochanek, Matthias, Michels, Guido, editor, and Kochanek, Matthias, editor

Published
2011
Full Text
View/download PDF

8. Infektiologie

Author

Kochanek, Matthias, Michels, Guido, Fätkenheuer, Gerd, Cornely, Oliver, Aurbach, Ute, Seifert, Harald, Gutschow, Christian, Waldschmidt, Dirk, Rybniker, Jan, Skouras, Emmanouil, Vehreschild, Maria J.G.T., Vehreschild, Janne, Michels, Guido, editor, and Kochanek, Matthias, editor

Published
2011
Full Text
View/download PDF

9. Infektiologie

Author

Kochanek, Matthias, Michels, Guido, Koch, Susann, Fätkenheuer, Gerd, Cornely, Oliver, Aurbach, Ute, Seifert, Harald, Gutschow, Christian, Waldschmitt, Dirk, von Gersdorff, Gero, Rybniker, Jan, Skouras, Emmanouil, Rüping, Maria, Vehreschild, Janne, Michels, Guido, editor, and Kochanek, Matthias, editor

Published
2010
Full Text
View/download PDF

10. Correction to: All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

Author

Schons, Maximilian J., Caliebe, Amke, Spinner, Christoph D., Classen, Annika Y., Pilgram, Lisa, Ruethrich, Maria M., Rupp, Jan, Nunes de Miranda, Susana M., Römmele, Christoph, Vehreschild, Janne, Jensen, Bjoern-Erik, Vehreschild, Maria, Degenhardt, Christian, Borgmann, Stefan, Hower, Martin, Hanses, Frank, Haselberger, Martina, and Friedrichs, Anette K.

Subjects
Microbiology (medical), Adult, Antimicrobial Stewardship, Infectious Diseases, SARS-CoV-2, Disease Progression, Correction, Humans, General Medicine, Anti-Bacterial Agents, COVID-19 Drug Treatment
Abstract

Reported antibiotic use in coronavirus disease 2019 (COVID-19) is far higher than the actual rate of reported bacterial co- and superinfection. A better understanding of antibiotic therapy in COVID-19 is necessary.6457 SARS-CoV-2-infected cases, documented from March 18, 2020, until February 16, 2021, in the LEOSS cohort were analyzed. As primary endpoint, the correlation between any antibiotic treatment and all-cause mortality/progression to the next more advanced phase of disease was calculated for adult patients in the complicated phase of disease and procalcitonin (PCT) ≤ 0.5 ng/ml. The analysis took the confounders gender, age, and comorbidities into account.Three thousand, six hundred twenty-seven cases matched all inclusion criteria for analyses. For the primary endpoint, antibiotic treatment was not correlated with lower all-cause mortality or progression to the next more advanced (critical) phase (n = 996) (both p 0.05). For the secondary endpoints, patients in the uncomplicated phase (n = 1195), regardless of PCT level, had no lower all-cause mortality and did not progress less to the next more advanced (complicated) phase when treated with antibiotics (p 0.05). Patients in the complicated phase with PCT 0.5 ng/ml and antibiotic treatment (n = 286) had a significantly increased all-cause mortality (p = 0.029) but no significantly different probability of progression to the critical phase (p 0.05).In this cohort, antibiotics in SARS-CoV-2-infected patients were not associated with positive effects on all-cause mortality or disease progression. Additional studies are needed. Advice of local antibiotic stewardship- (ABS-) teams and local educational campaigns should be sought to improve rational antibiotic use in COVID-19 patients.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results